Ten Years of EWAS

Area of Science:

• Genomics and Epigenetics
• Molecular Biology
• Computational Biology

Background:

• Epigenome-wide association studies (EWAS) have been pivotal in understanding DNA methylation's role in complex diseases over the past decade.
• The epigenome is increasingly recognized as a crucial research area for current scientific investigations.
• Technological advancements in DNA methylation microarrays and next-generation sequencing have significantly enhanced EWAS capabilities.

Purpose of the Study:

• To review the progress and achievements of EWAS in the field of complex diseases.
• To highlight the clinical applications and contributions of EWAS research.
• To discuss the challenges and future directions of EWAS.

Main Methods:

• Review of existing literature and research on EWAS.
• Analysis of technological platforms supporting EWAS, including microarrays and sequencing.
• Case studies focusing on the application of EWAS in four typical diseases.

Main Results:

• EWAS has provided valuable insights into DNA methylation patterns associated with various complex diseases.
• Significant contributions of EWAS to clinical applications and disease understanding have been demonstrated.
• The review details specific achievements in four distinct disease areas.

Conclusions:

• EWAS is a powerful tool for dissecting the epigenetic underpinnings of complex diseases.
• Continued technological innovation and methodological refinement will drive future EWAS advancements.
• Addressing current challenges will be key to unlocking the full potential of EWAS in clinical practice.